DARA BioSciences, Inc. Appoints Haywood Cochrane Jr. as Chairman of the Board of Directors and Names Paul Richardson as a New Board Member
3/1/2013 9:27:13 AM
More...
|
DARA BioSciences, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule
2/14/2013 9:55:24 AM
More...
|
DARA BioSciences, Inc. to Present at 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/11/2013 6:38:06 AM
More...
|
DARA BioSciences, Inc. to Present at the 6th Annual OneMedForum Conference
1/8/2013 6:38:26 AM
More...
|
DARA BioSciences, Inc. to Raise $2.8 Million Pursuant to Securities Purchase Agreement
1/2/2013 9:17:30 AM
More...
|
DARA BioSciences, Inc. Announces Submission of KRN5500 to FDA for Orphan Designation
11/29/2012 9:54:31 AM
More...
|
DARA BioSciences, Inc. Reports Financial Results for the Third Quarter 2012
11/15/2012 9:57:35 AM
More...
|
DARA BioSciences, Inc. Will Present at NYSSA Investing in Life Sciences Conference, November 29
11/12/2012 10:16:49 AM
More...
|
DARA BioSciences, Inc. Will Present at Singular Research Conference November 1
10/30/2012 7:51:36 AM
More...
|
DARA BioSciences, Inc. Launches Soltamox®, First and Only Liquid Version of Tamoxifen Citrate
10/22/2012 9:18:28 AM
More...
|
|